IDSA guideline update gives 9 updated recommendations on nirmatrelvir/ritonavir, remdesivir and molnupiravir for adults with mild to moderate COVID-19, based on a systematic review and GRADE, with an algorithm for choosing an antiviral.
Guideline
Shumaker et al. 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults